COMMUNIQUÉS West-GlobeNewswire
-
Passage Bio and Remix Therapeutics Announce Merger Agreement
24/06/2026 -
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
24/06/2026 -
ARS Pharmaceuticals Provides Commercial and Financial Updates
24/06/2026 -
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
24/06/2026 -
Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors
24/06/2026 -
Prometheuz Introduces Online Testosterone Replacement Therapy Platform for U.S. Men Experiencing Low Testosterone
24/06/2026 -
Jushi Holdings Inc. Announces Voting Results of Annual General and Special Shareholders’ Meeting
24/06/2026 -
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
24/06/2026 -
OSE Immunotherapeutics annonce les résultats de son Assemblée Générale Mixte 2026
24/06/2026 -
OSE Immunotherapeutics Reports Results of its 2026 Annual General Meeting
24/06/2026 -
Labviva Launches “The Agentic Crew”: A Purpose-Built AI Architecture to Transform Procurement in Regulated Industries
24/06/2026 -
SoldierStrong Donates Real® i-Series System to VA Boston Healthcare System to Advance Veteran Wellness and Mental Health Care
24/06/2026 -
Rendever Brings Social Prescribing to Senior Living with CommunityOS
24/06/2026 -
Femasys Regains Compliance with Nasdaq Listing Requirements
24/06/2026 -
Noom Launches Free Version of Its Powerful GLP-1 Companion — Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts
24/06/2026 -
Applied Biologics Announces Completion of Translational Research Supporting the Biologic Performance of XWRAP®
24/06/2026 -
Caregivers in Crisis: New Survey from Aeroflow Urology Reveals 77% of Caregivers are Drowning in Costs as Out-of-Pocket Expenses Reach a Breaking Point
24/06/2026 -
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
24/06/2026 -
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
Pages